title: Biologicals for rheumatoid arthritis.
authors.affiliation: Department of Medicine, Institute of Population Health, and Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada K1N 6N5. tugwell.bb@uottawa.ca
authors.forename: Peter
authors.initials: P
authors.lastname: Tugwell
authors.forename: Jasvinder A
authors.initials: JA
authors.lastname: Singh
authors.forename: George A
authors.initials: GA
authors.lastname: Wells
mesh_terms: D018501:Antirheumatic Agents / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000191:economics / Q000628:therapy*; D001688:Biological Products / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004333:Drug Administration Routes; D016527:Drug Costs; D016903:Drug Monitoring; D005260:Female; D005544:Forecasting; D006801:Humans; D008875:Middle Aged; D019057:Quality-Adjusted Life Years; D016032:Randomized Controlled Trials as Topic; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha